Absorb bioresorbable scaffold versus Xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: Rationale and design of the COMPARE ABSORB trial (2019) Chang CC, Onuma Y, Achenbach S, Barbato E, Chevalier B, Cook S, Dudek D, et al. Journal article Percutaneous coronary intervention of unprotected left main stenoses - Procedural data and outcome depending on SYNTAX I Score (2018) Blachutzik F, Achenbach S, Röther J, Tröbs M, Schneider R, Schlundt C, Marwan M Journal article Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R) (2016) Nef H, Wiebe J, Achenbach S, Muenzel T, Naber C, Richardt G, Mehilli J, et al. Journal article Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population (2015) Wiebe J, Liebetrau C, Dörr O, Wilkens E, Bauer T, Elsässer A, Achenbach S, et al. Journal article Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: Results from the ISAR-DESIRE 2 trial (2014) Kufner S, Byrne RA, de Waha A, Schulz S, Joner M, Laugwitz KL, Kastrati A Journal article Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy (2014) Ndrepepa G, Braun S, Tada T, Guerra E, Schunkert H, Laugwitz KL, Kastrati A Journal article